Literature DB >> 8136007

Is restricted antigen presentation the explanation for fetal allograft survival?

G W Wood1.   

Abstract

Mammalian embryos express paternal histocompatibility antigens which make them potential targets for the maternal immune system. The trophoblast is a major histocompatibility complex (MHC) antigen-negative barrier between mother and fetus which facilitates movement of antigenic molecules but prevents traffic of antigenic cells and is itself unable to present antigen. Gary Wood suggests that the lack of antigen presentation requirements for MHC class I-restricted T-cell responses prevent generation of paternal-antigen directed cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8136007     DOI: 10.1016/0167-5699(94)90020-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  4 in total

Review 1.  Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines.

Authors:  M P Piccinni; S Romagnani
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege.

Authors:  K Ohshima; M Nakashima; K Sonoda; M Kikuchi; T Watanabe
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

3.  Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood.

Authors:  Jill L Maron; Kirby L Johnson; Donna Slonim; Chao-Qiang Lai; Marco Ramoni; Gil Alterovitz; Zina Jarrah; Zinger Yang; Diana W Bianchi
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 4.  Trophoblast 'pseudo-tumorigenesis': significance and contributory factors.

Authors:  Rama Soundararajan; A Jagannadha Rao
Journal:  Reprod Biol Endocrinol       Date:  2004-03-25       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.